An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury

Chronic systemic sterile inflammation is implicated in the pathogenesis of cerebrovascular disease and white matter injury. Non-invasive blood markers for risk stratification and dissection of inflammatory molecular substrates in vivo are lacking. We sought to identify whether an interconnected network of inflammatory biomarkers centered on IL-18 and all previously associated with white matter lesions could detect overt and antecedent white matter changes in two populations at risk for cerebral small vessel disease. In a cohort of 167 older adults (mean age: 76, SD 7.1, 83 females) that completed a cognitive battery, physical examination, and blood draw in parallel with MR imaging including DTI, we measured cerebral white matter hyperintensities (WMH) and free water (FW). Concurrently, serum levels of a biologic network of inflammation molecules including MPO, GDF-15, RAGE, ST2, IL-18, and MCP-1 were measured. The ability of a log-transformed population mean-adjusted inflammatory composite score (ICS) to associate with MR variables was demonstrated in an age and total intracranial volume adjusted model. In this cohort, ICS was significantly associated with WMH (β = 0.222, p = 0.013), FW (β = 0.3, p = 0.01), and with the number of vascular risk factor diagnoses (r = 0.36, p<0.001). In a second cohort of 131 subjects presenting for the evaluation of acute neurologic deficits concerning for stroke, we used serum levels of 11 inflammatory biomarkers in an unbiased principal component analysis which identified a single factor significantly associated with WMH. This single factor was strongly correlated with the six component ICS identified in the first cohort and was associated with WMH in a generalized linear regression model adjusted for age and gender (p = 0.027) but not acute stroke. A network of inflammatory molecules driven by IL-18 is associated with overt and antecedent white matter injury resulting from cerebrovascular disease and may be a promising peripheral biomarker for vascular white matter injury.

[1]  A. Stępień,et al.  IL-1α and IL-6 predict vascular events or death in patients with cerebral small vessel disease-Data from the SHEF-CSVD study. , 2019, Advances in medical sciences.

[2]  Jackson T. Wright,et al.  Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. , 2019, JAMA.

[3]  J. O'Brien,et al.  Inflammation and cerebral small vessel disease: A systematic review , 2019, Ageing Research Reviews.

[4]  Ninon Burgos,et al.  New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .

[5]  Richard Frayne,et al.  Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations , 2019, Alzheimer's & Dementia.

[6]  C. Decarli,et al.  Cerebral white matter free water , 2019, Neurology.

[7]  J. Williamson,et al.  Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial , 2019, JAMA.

[8]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[9]  A. Stępień,et al.  Cerebral and Extracerebral Vasoreactivity in Patients With Different Clinical Manifestations of Cerebral Small‐Vessel Disease: Data From the Significance of Hemodynamic and Hemostatic Factors in the Course of Different Manifestations of Cerebral Small‐Vessel Disease Study , 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[10]  W. Niessen,et al.  Practical Small Vessel Disease Score Relates to Stroke, Dementia, and Death: The Rotterdam Study , 2018, Stroke.

[11]  C. DeCarli,et al.  “Liquid Biopsy” of White Matter Hyperintensity in Functionally Normal Elders , 2018, Front. Aging Neurosci..

[12]  Wenli Hu,et al.  Twenty-four-hour ambulatory blood pressure variability is associated with total magnetic resonance imaging burden of cerebral small-vessel disease , 2018, Clinical interventions in aging.

[13]  Yaping Yan,et al.  Emerging Role of Immunity in Cerebral Small Vessel Disease , 2018, Front. Immunol..

[14]  G. Kaplanski Interleukin‐18: Biological properties and role in disease pathogenesis , 2017, Immunological reviews.

[15]  F. Spertini,et al.  Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease , 2017, Annals of the rheumatic diseases.

[16]  C. Jack,et al.  Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study , 2017, Stroke.

[17]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[18]  Evan Fletcher,et al.  Aortic Stiffness, Increased White Matter Free Water, and Altered Microstructural Integrity: A Continuum of Injury , 2017, Stroke.

[19]  J. Wardlaw,et al.  Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study , 2017, Alzheimer's & Dementia.

[20]  J. Kelsen,et al.  Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. , 2017, The Journal of allergy and clinical immunology.

[21]  J. Staals,et al.  Total Cerebral Small Vessel Disease MRI Score Is Associated with Cognitive Decline in Executive Function in Patients with Hypertension , 2016, Front. Aging Neurosci..

[22]  David S Liebeskind,et al.  Principles of precision medicine in stroke , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  J. Kramer,et al.  MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes , 2016, Alzheimer's & dementia.

[24]  O. Benavente,et al.  Abstract WP160: Inflammatory Markers and Outcomes After Lacunar Stroke: the Levels of Inflammatory Markers in Treatment of Stroke Study , 2016, Stroke.

[25]  C. DeCarli,et al.  Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke , 2015, Stroke.

[26]  S. Carmichael,et al.  Molecular disorganization of axons adjacent to human lacunar infarcts. , 2015, Brain : a journal of neurology.

[27]  P. Wolf,et al.  Inflammatory biomarkers, cerebral microbleeds, and small vessel disease , 2015, Neurology.

[28]  Mark D. Johnson,et al.  C-Reactive Protein as a Prognostic Marker After Lacunar Stroke: Levels of Inflammatory Markers in the Treatment of Stroke Study , 2014, Stroke.

[29]  C. Dinarello,et al.  Interleukin-18 and IL-18 Binding Protein , 2013, Front. Immunol..

[30]  Owen T. Carmichael,et al.  Coevolution of brain structures in amnestic mild cognitive impairment , 2013, NeuroImage.

[31]  A. Stępień,et al.  Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study—Study Rationale and Protocol , 2013, Neuroscience journal.

[32]  Evan Fletcher,et al.  Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study , 2012, The Lancet Neurology.

[33]  Evan Fletcher,et al.  Adaptive image segmentation for robust measurement of longitudinal brain tissue change , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[34]  Robert J. van Oostenbrugge,et al.  Vascular inflammation in cerebral small vessel disease , 2012, Neurobiology of Aging.

[35]  K. Kitagawa,et al.  Relations of Blood Inflammatory Marker Levels With Cerebral Microbleeds , 2011, Stroke.

[36]  M. Woodward,et al.  Interleukin 18 and coronary heart disease: Prospective study and systematic review , 2011, Atherosclerosis.

[37]  C. DeCarli,et al.  Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). , 2011, Atherosclerosis.

[38]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[39]  L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[40]  C. Dinarello,et al.  High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. , 2010, Journal of autoimmunity.

[41]  B. Conti,et al.  Interleukin 18 in the CNS , 2010, Journal of Neuroinflammation.

[42]  J. P. de Rivero Vaccari,et al.  Inhibition of the Inflammasome Complex Reduces the Inflammatory Response after Thromboembolic Stroke in Mice , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  S. Rabkin The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease , 2009, Nature Clinical Practice Cardiovascular Medicine.

[44]  E. Air,et al.  Clinical Prediction of Functional Outcome After Ischemic Stroke: The Surprising Importance of Periventricular White Matter Disease and Race , 2009, Stroke.

[45]  P. Langhorne,et al.  Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke , 2009, Cerebrovascular Diseases.

[46]  J. Danesh,et al.  Leptin and coronary heart disease: prospective study and systematic review. , 2009, Journal of the American College of Cardiology.

[47]  C. Dinarello,et al.  Interleukin-18 Binding Protein in the Sera of Patients with Wegener’s Granulomatosis , 2008, Journal of Clinical Immunology.

[48]  C. Dinarello,et al.  Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. , 2005, Blood.

[49]  D. Harvey,et al.  Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden , 2005, Stroke.

[50]  Paul M. Ridker,et al.  Inflammation as a Cardiovascular Risk Factor , 2004, Circulation.

[51]  J. Losy,et al.  Interleukin-18 in acute ischaemic stroke patients , 2003, Neurological Sciences.

[52]  F. Cambien,et al.  Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina , 2002, Circulation.

[53]  G. Stoll,et al.  Interleukin-18 Expression after Focal Ischemia of the Rat Brain: Association with the Late-Stage Inflammatory Response , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  C. Jack,et al.  FLAIR histogram segmentation for measurement of leukoaraiosis volume , 2001, Journal of magnetic resonance imaging : JMRI.

[55]  Natalia S. Rost,et al.  Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study , 2001, Stroke.

[56]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[57]  N. Rothwell,et al.  Detection of the interleukin 18 family in rat brain by RT-PCR. , 2000, Brain research. Molecular brain research.

[58]  M Eisenstein,et al.  Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Fantuzzi,et al.  IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  N. Rothwell,et al.  Cloning of rat brain interleukin-18 cDNA , 1998, Molecular Psychiatry.

[61]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[62]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.